GoodRx Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
GoodRx Holdings, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue792.32750.27766.55745.42550.70
Cost of Revenue48.2262.4365.0846.7229.59
Gross Profit744.11687.84701.48698.71521.11
Operating Expenses
Research & Development123.75126.44143.14125.8661.82
Selling, General & Administrative464.62450.41566.07524.90714.52
Operating Expenses657.91637.82699.74685.30794.76
Operating Income86.2050.021.7413.41-273.65
Other Income/Expense
Interest Income23.2732.179.270.060.16
Interest Expense-52.92-56.7334.2423.64-27.91
Other Income/Expense-2.66-4.01-767.1335.090.02
Income
Income Before Tax31.46-55.57-23.23-10.18-303.45
Income Tax Expense15.07-46.709.6015.08-9.83
Net Income16.39-8.87-32.83-25.25-293.62
Net Income - Continuous Operations16.39-8.87-32.83-25.250.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA99.5467.0965.1948.00-259.62
EBIT86.2050.0211.0113.47-273.65
Depreciation & Amortization13.3417.0789.3734.5414.03
Earnings Per Share
Basic EPS-----1.00
Diluted EPS-----1.00
Basic Shares Outstanding385.74410.32412.86409.98274.70
Diluted Shares Outstanding392.17410.32412.86409.98274.70